Why are pharmacy acquisition costs and consumer prescription drug price indices apparently diverging

Pharmacy acquisition costs for prescription (Rx ) drugs have been trending below levels implied by the Bureau of Labor Statistics' (BLS) Consumer Price Index for Rx drugs, with the divergence higher when generic approvals are high. Dropping the first 6 months of generic sales from price indices calculated from pharmacy acquisition costs eliminates most of the difference between such indices and BLS indices.